{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:37:42Z","timestamp":1780349862508,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["081814\/Z\/06\/Z"],"award-info":[{"award-number":["081814\/Z\/06\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3033-9","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T11:16:13Z","timestamp":1520334973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Phan Vuong Khac","family":"Thai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Thi Minh","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Hanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Quynh","family":"Nhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Sy","family":"Kiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Huu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Huy","family":"Dung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Ngoc","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thuong","family":"Thuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Ngoc","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph\u1ea1m Th\u1ecb Th\u00fay","family":"Li\u1ec5u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguy\u1ec5n Th\u1ecb","family":"H\u1ed3ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0110\u00e0o C\u00f4ng","family":"\u0110i\u1ec7p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguy\u1ec5n Th\u1ecb Kim","family":"Thanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguy\u1ec5n V\u0103n","family":"H\u1ed9i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguy\u1ec5n V\u0103n","family":"Ngh\u0129a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tr\u01b0\u01a1ng Ng\u1ecdc","family":"\u0110\u1ea1i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho\u00e0ng Quang","family":"Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguy\u1ec5n V\u0103n","family":"Th\u01a1m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9109-350X","authenticated-orcid":false,"given":"Maxine","family":"Caws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"3033_CR1","unstructured":"World Health Organisation Global Report. 2016. Geneva, Switzerland. WHO\/HTM\/TB\/201613E. Available at: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ ."},{"key":"3033_CR2","unstructured":"World Health Organisation. Anti-tuberculosis drug resistance in the World. Fourth global report. Report number WHO\/HTM\/TB\/2008.39 http:\/\/whqlibdoc.who.int\/hq\/2008\/WHO_HTM_TB_2008.394_eng.pdf ."},{"issue":"2","key":"3033_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","volume":"149","author":"W Lew","year":"2008","unstructured":"Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med. 2008;149(2):123\u201334.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3033_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000146","volume":"6","author":"D Menzies","year":"2009","unstructured":"Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med. 2009;6(9):e1000146.","journal-title":"PLoS Med"},{"issue":"9","key":"3033_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000150","volume":"6","author":"D Menzies","year":"2009","unstructured":"Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, Burman W, et al. Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med. 2009;6(9):e1000150.","journal-title":"PLoS Med"},{"key":"3033_CR6","doi-asserted-by":"crossref","unstructured":"Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2016;","DOI":"10.1016\/S1473-3099(16)30407-8"},{"key":"3033_CR7","doi-asserted-by":"crossref","unstructured":"D'Ambrosio L, Migliori GB, Sotgiu G. Time to review treatment of isoniazid-resistant tuberculosis? Lancet Infect Dis. 2016;","DOI":"10.1016\/S1473-3099(16)30381-4"},{"key":"3033_CR8","unstructured":"World Health Organisation. Treatment of tuberculosis: guidelines for national programmes. 4th Edn. Report number: http:\/\/www.who.int\/tb\/publications\/9789241547833\/en\/ accessed 11 august 2017."},{"issue":"12","key":"3033_CR9","first-page":"1318","volume":"10","author":"PR Donald","year":"2006","unstructured":"Donald PR, Maher D, Maritz JS, Qazi S. Ethambutol dosage for the treatment of children: literature review and recommendations. Int J Tuberc Lung Dis. 2006;10(12):1318\u201330.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"4","key":"3033_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.5588\/ijtld.11.0766","volume":"17","author":"N Ezer","year":"2013","unstructured":"Ezer N, Benedetti A, Darvish-Zargar M, Menzies D. Incidence of ethambutol-related visual impairment during treatment of active tuberculosis. Int J Tuberc Lung Dis. 2013;17(4):447\u201355.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"2","key":"3033_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1749-6632.1966.tb45532.x","volume":"135","author":"JE Leibold","year":"1966","unstructured":"Leibold JE. The ocular toxicity of ethambutol and its relation to dose. Ann N Y Acad Sci. 1966;135(2):904\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3033_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/0007-0971(86)90066-5","volume":"80","author":"VK Chatterjee","year":"1986","unstructured":"Chatterjee VK, Buchanan DR, Friedmann AI, Green M. Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest. 1986;80(3):288\u201391.","journal-title":"Br J Dis Chest"},{"issue":"2","key":"3033_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1183\/09031936.00005613","volume":"43","author":"S Law","year":"2014","unstructured":"Law S, Benedetti A, Oxlade O, Schwartzman K, Menzies D. Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance. Eur Respir J. 2014;43(2):566\u201381.","journal-title":"Eur Respir J"},{"issue":"15","key":"3033_CR14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa055524","volume":"355","author":"DA Moore","year":"2006","unstructured":"Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355(15):1539\u201350.","journal-title":"N Engl J Med"},{"issue":"10","key":"3033_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S1473-3099(10)70165-1","volume":"10","author":"J Minion","year":"2010","unstructured":"Minion J, Leung E, Menzies D, Pai M. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(10):688\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"3033_CR16","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1128\/JCM.41.6.2323-2329.2003","volume":"41","author":"S Honore-Bouakline","year":"2003","unstructured":"Honore-Bouakline S, Vincensini JP, Giacuzzo V, Lagrange PH, Herrmann JL. Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol. 2003;41(6):2323\u20139.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3033_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000034","volume":"4","author":"M Caws","year":"2008","unstructured":"Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT, et al. The influence of host and bacterial genotype on the development of disseminated disease with mycobacterium tuberculosis. PLoS Pathog. 2008;4(3):e1000034.","journal-title":"PLoS Pathog"},{"key":"3033_CR18","unstructured":"Isogen Life Science (An Ocimum Biosolutions Company). Spoligotyping - a PCR-based method to simultaneously detect and type Mycobacterium tuberculosis complex bacteria manual. http:\/\/www.springerlink.com\/content\/t78281g513k43397\/#section=67734&page=1&locus=0 ."},{"issue":"4","key":"3033_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.meegid.2012.02.004","volume":"12","author":"C Demay","year":"2012","unstructured":"Demay C, Liens B, Burguiere T, Hill V, Couvin D, Millet J, et al. SITVITWEB--a publicly available international multimarker database for studying mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol. 2012;12(4):755\u201366.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"3033_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12866-016-0784-6","volume":"16","author":"VA Nguyen","year":"2016","unstructured":"Nguyen VA, Banuls AL, Tran TH, Pham KL, Nguyen TS, Nguyen HV, et al. Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam. BMC Microbiol. 2016;16(1):167.","journal-title":"BMC Microbiol"},{"issue":"7","key":"3033_CR21","first-page":"900","volume":"13","author":"TN Buu","year":"2009","unstructured":"Buu TN, Huyen MN, Lan NT, Quy HT, Hen NV, Zignol M, et al. The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. Int J Tuberc Lung Dis. 2009;13(7):900\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"3033_CR22","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1128\/AAC.00541-09","volume":"53","author":"DA Duong","year":"2009","unstructured":"Duong DA, Nguyen TH, Nguyen TN, Dai VH, Dang TM, Vo SK, et al. Beijing genotype of mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob Agents Chemother. 2009;53(11):4835\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"3033_CR23","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1128\/JCM.01181-06","volume":"44","author":"M Caws","year":"2006","unstructured":"Caws M, Thwaites G, Stepniewska K, Nguyen TN, Nguyen TH, Nguyen TP, et al. Beijing genotype of mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol. 2006;44(11):3934\u20139.","journal-title":"J Clin Microbiol"},{"issue":"17","key":"3033_CR24","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","volume":"371","author":"SH Gillespie","year":"2014","unstructured":"Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, et al. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med. 2014;371(17):1577\u201387.","journal-title":"N Engl J Med"},{"issue":"17","key":"3033_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","volume":"371","author":"A Jindani","year":"2014","unstructured":"Jindani A, Harrison TS, Nunn AJ, Phillips PP, Churchyard GJ, Charalambous S, et al. High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med. 2014;371(17):1599\u2013608.","journal-title":"N Engl J Med"},{"issue":"17","key":"3033_CR26","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","volume":"371","author":"CS Merle","year":"2014","unstructured":"Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, et al. A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med. 2014;371(17):1588\u201398.","journal-title":"N Engl J Med"},{"issue":"7","key":"3033_CR27","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1128\/JCM.00561-08","volume":"46","author":"C Abe","year":"2008","unstructured":"Abe C, Kobayashi I, Mitarai S, Wada M, Kawabe Y, Takashima T, et al. Biological and molecular characteristics of mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan. J Clin Microbiol. 2008;46(7):2263\u20138.","journal-title":"J Clin Microbiol"},{"key":"3033_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2180-9-39","volume":"9","author":"ER Dalla Costa","year":"2009","unstructured":"Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, Cafrune PI, et al. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 2009;9:39.","journal-title":"BMC Microbiol"},{"issue":"8","key":"3033_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1469-0691.2006.01495.x","volume":"12","author":"HR van Doorn","year":"2006","unstructured":"van Doorn HR, de Haas PE, Kremer K, Vandenbroucke-Grauls CM, Borgdorff MW, van Soolingen D. Public health impact of isoniazid-resistant mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in the Netherlands. Clin Microbiol Infect. 2006;12(8):769\u201375.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"3033_CR30","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1086\/317598","volume":"182","author":"D van Soolingen","year":"2000","unstructured":"van Soolingen D, de Haas PE, van Doorn HR, Kuijper E, Rinder H, Borgdorff MW. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of mycobacterium tuberculosis in the Netherlands. J Infect Dis. 2000;182(6):1788\u201390.","journal-title":"J Infect Dis"},{"key":"3033_CR31","doi-asserted-by":"crossref","unstructured":"Nunn AJ, Jindani A, Enarson DA, Study Ai: Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis. Int J Tuberc Lung Dis 2011, 15(6):741\u2013745.","DOI":"10.5588\/ijtld.10.0392"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3033-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:29:57Z","timestamp":1693571397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3033-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3033"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3033-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"21 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Research Board of Pham Ngoc Thach Hospital as the supervisory institution of the district TB Units (DTUs) in southern Vietnam, Ho Chi Minh City Health Services and the Oxford University Tropical Research Ethics Committee (Oxtrec 030\u201307). Written informed consent was obtained from all patients prior to screening for INH susceptibility and, if resistant by MODS testing, a second written informed consent was obtained for enrolment into the INH study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"112"}}